Global Peripheral Neuropathy Treatment Market Research Report 2023

Report ID: 1975261 | Published Date: Oct 2024 | No. of Page: 82 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Calcium Channel α2-delta Ligands
        1.2.3 Antidepressants
        1.2.4 Opioids
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Peripheral Neuropathy Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Platinum Agents
        1.3.3 Taxanes
        1.3.4 Vinca Alkaloids
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peripheral Neuropathy Treatment Market Perspective (2017-2028)
    2.2 Peripheral Neuropathy Treatment Growth Trends by Region
        2.2.1 Peripheral Neuropathy Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peripheral Neuropathy Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Peripheral Neuropathy Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Peripheral Neuropathy Treatment Market Dynamics
        2.3.1 Peripheral Neuropathy Treatment Industry Trends
        2.3.2 Peripheral Neuropathy Treatment Market Drivers
        2.3.3 Peripheral Neuropathy Treatment Market Challenges
        2.3.4 Peripheral Neuropathy Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peripheral Neuropathy Treatment Players by Revenue
        3.1.1 Global Top Peripheral Neuropathy Treatment Players by Revenue (2017-2022)
        3.1.2 Global Peripheral Neuropathy Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Peripheral Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peripheral Neuropathy Treatment Revenue
    3.4 Global Peripheral Neuropathy Treatment Market Concentration Ratio
        3.4.1 Global Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peripheral Neuropathy Treatment Revenue in 2021
    3.5 Peripheral Neuropathy Treatment Key Players Head office and Area Served
    3.6 Key Players Peripheral Neuropathy Treatment Product Solution and Service
    3.7 Date of Enter into Peripheral Neuropathy Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Neuropathy Treatment Breakdown Data by Type
    4.1 Global Peripheral Neuropathy Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2023-2028)
5 Peripheral Neuropathy Treatment Breakdown Data by Application
    5.1 Global Peripheral Neuropathy Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peripheral Neuropathy Treatment Market Size (2017-2028)
    6.2 North America Peripheral Neuropathy Treatment Market Size by Country (2017-2022)
    6.3 North America Peripheral Neuropathy Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Peripheral Neuropathy Treatment Market Size (2017-2028)
    7.2 Europe Peripheral Neuropathy Treatment Market Size by Country (2017-2022)
    7.3 Europe Peripheral Neuropathy Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peripheral Neuropathy Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Peripheral Neuropathy Treatment Market Size (2017-2028)
    9.2 Latin America Peripheral Neuropathy Treatment Market Size by Country (2017-2022)
    9.3 Latin America Peripheral Neuropathy Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peripheral Neuropathy Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Detail
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Peripheral Neuropathy Treatment Introduction
        11.1.4 Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.1.5 Eli Lilly Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Detail
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Peripheral Neuropathy Treatment Introduction
        11.2.4 Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Peripheral Neuropathy Treatment Introduction
        11.3.4 Novartis Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Peripheral Neuropathy Treatment Introduction
        11.4.4 Pfizer Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 Aptinyx
        11.5.1 Aptinyx Company Detail
        11.5.2 Aptinyx Business Overview
        11.5.3 Aptinyx Peripheral Neuropathy Treatment Introduction
        11.5.4 Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.5.5 Aptinyx Recent Development
    11.6 Regenacy Pharmaceuticals
        11.6.1 Regenacy Pharmaceuticals Company Detail
        11.6.2 Regenacy Pharmaceuticals Business Overview
        11.6.3 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Introduction
        11.6.4 Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.6.5 Regenacy Pharmaceuticals Recent Development
    11.7 TEVA Pharmaceutical Industries
        11.7.1 TEVA Pharmaceutical Industries Company Detail
        11.7.2 TEVA Pharmaceutical Industries Business Overview
        11.7.3 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Introduction
        11.7.4 TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.7.5 TEVA Pharmaceutical Industries Recent Development
    11.8 Immune Pharmaceuticals
        11.8.1 Immune Pharmaceuticals Company Detail
        11.8.2 Immune Pharmaceuticals Business Overview
        11.8.3 Immune Pharmaceuticals Peripheral Neuropathy Treatment Introduction
        11.8.4 Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2017-2022)
        11.8.5 Immune Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Calcium Channel α2-delta Ligands
    Table 3. Key Players of Antidepressants
    Table 4. Key Players of Opioids
    Table 5. Key Players of Others
    Table 6. Global Peripheral Neuropathy Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Peripheral Neuropathy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Peripheral Neuropathy Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Peripheral Neuropathy Treatment Market Share by Region (2017-2022)
    Table 10. Global Peripheral Neuropathy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Peripheral Neuropathy Treatment Market Share by Region (2023-2028)
    Table 12. Peripheral Neuropathy Treatment Market Trends
    Table 13. Peripheral Neuropathy Treatment Market Drivers
    Table 14. Peripheral Neuropathy Treatment Market Challenges
    Table 15. Peripheral Neuropathy Treatment Market Restraints
    Table 16. Global Peripheral Neuropathy Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Peripheral Neuropathy Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Neuropathy Treatment as of 2021)
    Table 19. Ranking of Global Top Peripheral Neuropathy Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Peripheral Neuropathy Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Peripheral Neuropathy Treatment Product Solution and Service
    Table 23. Date of Enter into Peripheral Neuropathy Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Peripheral Neuropathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Peripheral Neuropathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Peripheral Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Peripheral Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Peripheral Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Peripheral Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Peripheral Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Peripheral Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Eli Lilly Company Detail
    Table 44. Eli Lilly Business Overview
    Table 45. Eli Lilly Peripheral Neuropathy Treatment Product
    Table 46. Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 47. Eli Lilly Recent Development
    Table 48. Johnson & Johnson Company Detail
    Table 49. Johnson & Johnson Business Overview
    Table 50. Johnson & Johnson Peripheral Neuropathy Treatment Product
    Table 51. Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 52. Johnson & Johnson Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Peripheral Neuropathy Treatment Product
    Table 56. Novartis Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Pfizer Company Detail
    Table 59. Pfizer Business Overview
    Table 60. Pfizer Peripheral Neuropathy Treatment Product
    Table 61. Pfizer Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 62. Pfizer Recent Development
    Table 63. Aptinyx Company Detail
    Table 64. Aptinyx Business Overview
    Table 65. Aptinyx Peripheral Neuropathy Treatment Product
    Table 66. Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 67. Aptinyx Recent Development
    Table 68. Regenacy Pharmaceuticals Company Detail
    Table 69. Regenacy Pharmaceuticals Business Overview
    Table 70. Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Product
    Table 71. Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 72. Regenacy Pharmaceuticals Recent Development
    Table 73. TEVA Pharmaceutical Industries Company Detail
    Table 74. TEVA Pharmaceutical Industries Business Overview
    Table 75. TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Product
    Table 76. TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 77. TEVA Pharmaceutical Industries Recent Development
    Table 78. Immune Pharmaceuticals Company Detail
    Table 79. Immune Pharmaceuticals Business Overview
    Table 80. Immune Pharmaceuticals Peripheral Neuropathy Treatment Product
    Table 81. Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2017-2022) & (US$ Million)
    Table 82. Immune Pharmaceuticals Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peripheral Neuropathy Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Calcium Channel α2-delta Ligands Features
    Figure 3. Antidepressants Features
    Figure 4. Opioids Features
    Figure 5. Others Features
    Figure 6. Global Peripheral Neuropathy Treatment Market Share by Application in 2021 & 2028
    Figure 7. Platinum Agents Case Studies
    Figure 8. Taxanes Case Studies
    Figure 9. Vinca Alkaloids Case Studies
    Figure 10. Others Case Studies
    Figure 11. Peripheral Neuropathy Treatment Report Years Considered
    Figure 12. Global Peripheral Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Peripheral Neuropathy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Peripheral Neuropathy Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Peripheral Neuropathy Treatment Market Share by Players in 2021
    Figure 16. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Neuropathy Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Peripheral Neuropathy Treatment Revenue in 2021
    Figure 18. North America Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Peripheral Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 20. United States Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Peripheral Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 24. Germany Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Peripheral Neuropathy Treatment Market Share by Region (2017-2028)
    Figure 32. China Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Peripheral Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Peripheral Neuropathy Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Peripheral Neuropathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Eli Lilly Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 47. Johnson & Johnson Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 48. Novartis Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 49. Pfizer Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 50. Aptinyx Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 51. Regenacy Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 52. TEVA Pharmaceutical Industries Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 53. Immune Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Johnson & Johnson
Novartis
Pfizer
Aptinyx
Regenacy Pharmaceuticals
TEVA Pharmaceutical Industries
Immune Pharmaceuticals
Frequently Asked Questions
Peripheral Neuropathy Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peripheral Neuropathy Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peripheral Neuropathy Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nylon Filament Yarn

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Click Fraud Software

Click Fraud Software market is segmented by players, region (country), by Type and by Application ... Read More